Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds.
from Gadgets Now https://ift.tt/3c6t2Hs
Wednesday, May 27, 2020
Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment